kıbrıs ingiltere londra lefkoşa
DOLAR
7,3733
EURO
8,9838
STERLIN
10,1147
BITCOIN
$33.220
Adana Adıyaman Afyon Ağrı Aksaray Amasya Ankara Antalya Ardahan Artvin Aydın Balıkesir Bartın Batman Bayburt Bilecik Bingöl Bitlis Bolu Burdur Bursa Çanakkale Çankırı Çorum Denizli Diyarbakır Düzce Edirne Elazığ Erzincan Erzurum Eskişehir Gaziantep Giresun Gümüşhane Hakkari Hatay Iğdır Isparta İstanbul İzmir K.Maraş Karabük Karaman Kars Kastamonu Kayseri Kırıkkale Kırklareli Kırşehir Kilis Kocaeli Konya Kütahya Malatya Manisa Mardin Mersin Muğla Muş Nevşehir Niğde Ordu Osmaniye Rize Sakarya Samsun Siirt Sinop Sivas Şanlıurfa Şırnak Tekirdağ Tokat Trabzon Tunceli Uşak Van Yalova Yozgat Zonguldak
LONDRA
Parçalı Bulutlu
5°C
LONDRA
5°C
Parçalı Bulutlu
26 Oca, Sal Sağanak Yağışlı
0°C
27 Oca, Çar Sağanak Yağışlı
3°C
28 Oca, Per Kasvetli
9°C
29 Oca, Cum Sağanak Yağışlı
5°C

Medical cannabis prescriptions available from November

Medical cannabis prescriptions available from November
24.10.2018
0
A+
A-

DOCTORS will be able to prescribe cannabis products to patients from 1 November, the Home Secretary Sajid Javid says.

The new regulations apply to England, Wales, Scotland and Northern Ireland.

Mr Javid decided to relax the rules on when cannabis products could be given to patients after a review into medicinal cannabis earlier this year.

This followed an outcry over Alfie Dingley and Billy Caldwell being denied access to cannabis oil.

The parents of the two young epilepsy sufferers said the product helped to control their seizures.

Alfie’s mother, Hannah Deacon, welcomed the move, saying: “We urge the medical world to get behind these reforms so they can help the tens of thousands of people who are in urgent need of help.

“I have personally seen how my son’s life has changed due to the medical cannabis he is now prescribed.”

Professor Mike Barnes, the medical cannabis expert who secured the first long-term licence for its use for Alfie, encouraged doctors to embrace the changes to the laws on prescribing medicinal cannabis.

An initial review by chief medical officer Dame Sally Davies concluded there was evidence medicinal cannabis has therapeutic benefits.

The Advisory Council on the Misuse of Drugs (ACMD), which carried out the second part of the review, then said doctors should be able to prescribe medicinal cannabis provided products met safety standards.

It recommended cannabis-derived medicinal products should be placed in schedule two of the Misuse of Drugs Regulations 2001.

Cannabis has previously been classed as a schedule one drug, meaning it is thought to have no therapeutic value but can be used for the purposes of research with a Home Office licence.

Yorumlar

Henüz yorum yapılmamış. İlk yorumu yukarıdaki form aracılığıyla siz yapabilirsiniz.